The accurate and valid assessment of body composition is essential for the diagnostic evaluation of nutritional status, identifying relevant outcome measures and for determining the effectiveness of current and future nutritional interventions.
Introduction
The accurate and valid assessment of body composition is essential for the diagnostic evaluation of nutritional status, identifying relevant outcome measures and for determining the effectiveness of current and future nutritional interventions.
Ongoing developments in technology and understanding of the influences of body composition on risk and outcome provide practitioners with new opportunities to enhance current practice and lead future improvements in practice. In turn, it is hoped that this will lead to an increased understanding of the effect of specific nutritional interventions on health outcomes and serve to further support the effectiveness of the dietitian.
Much attention has been given to identification and assessment of sarcopenia, originally defined as the age related loss of muscle mass (2) . This in turn, has driven an increased focus on identifying and using valid methods for the assessment of muscle mass. Furthermore, results of longitudinal studies have highlighted that the loss of mass and the loss of strength (or conversely gain) does not occur in a linear manner, thereby implying a disassociation in the relationship between mass and strength (3) . For example in ageing it has been suggested that muscle strength is lost at a rate 2-5 times faster than muscle mass in men and women (4) . Additionally, the rate of loss may not be uniform across the body with the rate of loss of lower limbs potentially more than twice that of the upper limbs and notable gender and ethnic differences have been observed (4, 5) .
Increasingly it has been recognized, that whilst muscle mass is a key influence on muscle strength, it is not the sole influence and there are several other important factors (6, 7, 8) . These include neural factors and factors affecting the functionality of the muscle itself, such as: the presence of an underlying disease e.g. myopathy, neuropathy, presence of intramuscular adipose tissue (IMAT), inflammation, hypoxia, peripheral vascular disease, oxidative stress, electrolyte imbalance and inactivity. In addition, particular nutritional factors such as vitamin D or iron deficiencies, disorders of fat and glucose metabolism, short or longer term starvation and repletion (feeding) (9) (10) (11) (12) (13) .
In view of this increased understanding, the term dynapenia meaning 'poverty of strength' has been proposed (7) to differentiate between reduced muscle mass and reduced muscle strength. Whilst it was proposed that this term be used to refer to age related loss of muscle strength, the concept of dynapenia is also likely to be applicable to the loss of muscle strength at any age which may be due to factors described above (8, 11) .
Further to this, it is increasingly being recognized that the functionality of muscle mass may be more important than absolute mass in terms of disability risk and mortality outcome (4, 8, 14) . In terms of outcomes, this suggests that rather than solely focusing on changes in muscle mass, it may be more appropriate to aim for improvements in muscle strength, be that through the use of novel nutritional and/or pharmacological or exercise interventions (14) .
In light of this increased understanding, it could be argued that the assessment and monitoring of body composition should increasingly focus on methods that can demonstrate impairment and improvement of muscle strength and function. It is also likely that such methods provide valuable early indicators of risk and mortality and are more sensitive to nutritional depletion and repletion than methods, which solely assess mass (4, 12, 15) . However, in order to better understand the relationship between and the influences on muscle mass versus muscle function it appears prudent to use such methods in a complementary manner (16).
Computed tomography (CT) and magnetic resonance imaging (MRI)
The use of imaging technology, particularly computed tomography (CT) and magnetic resonance imaging (MRI), for the assessment of body composition, has undoubtedly led to an increased understanding of body composition and its influence on disease risk and outcome. These methods are considered to be gold standard reference technologies for body composition analysis at a tissue level (17). As such, they are considered to be valid, accurate, precise and rapid methods that have the potential to detect small changes in body composition (17, 18). These technologies have been used to identify ectopic and inter/intramuscular adipose tissue and develop an increased understanding of the difference between visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT). Furthermore the technology has assisted in elucidating the identification of sub phenotypes in the general population whose risks are not comparable to their body mass index (BMI) or waist circumference (19). As such, CT and MRI have highlighted the limitations of more traditional methods of body composition assessment and the need to increasingly think beyond these.
The determination of, and distinction between tissues evaluated by CT, is based on known differences between tissues in terms of their density (3) . CT images consist of pixels with assigned Hounsfield units (HU). Hounsfield units are measures of tissue attenuation and pre-defined radiation attenuation ranges are used to demarcate tissues. Typically, ranges of -190 to -30 HU define subcutaneous adipose tissue, -150 to -50 HU for visceral adipose tissue and -29 and +150 HU for skeletal muscle and more recently a range of -29 to +29HU to define low muscle attenuation (reflective of increased levels of fatty infiltration) have been proposed (20) . The tissue area (cm 2 ) of cross-sectional images is then calculated by multiplying the number of pixels for a given tissue by the surface area, which can be determined manually or with specific automated software, with the latter considered to improve objectivity of the analysis (17, 21). In a manner, similar to CT, MRI is also able to quantify and determine adipose and skeletal muscle tissues (22). However, MRI differs from CT in how images are acquired. MRI does not involve the use of ionizing radiation, but instead relies on the tissue specific properties of proton density (i.e. density of hydrogen atoms) and longitudinal (T1) and transverse (T2) relaxation times (23). As a result, MRI in comparison to CT is considered to be safer, which has allowed whole-body and repeated measurements to be conducted. MRI uses the body's inherent magnetic properties to create detailed images. Hydrogen protons within tissues act like magnets and when participants are placed within an MRI scanner the protons within tissues align. Pulsed radiofrequency waves are then used to activate the atomic protons to absorb energy. (24). When the radiofrequency pulse is turned off, the protons release energy which is absorbed in the form of a radiofrequency signal. This signal is used to generate cross-sectional images from which the type and quantity of tissue can be determined in a manner similar to CT (22).
Although it is possible to perform whole-body CT and MRI scans, this is undesirable due to the time involved and the high levels of radiation exposure associated with CT. It is therefore common practice to perform regional abdominal single slice scans at the 3 rd or 4 th lumbar vertebra (L3-L4 DXA scans use low dose x-rays of two energies (typically 40keV and 70keV) which are passed through an individual (51) . Estimates of body composition are derived based on the principle that the body is a two-compartment model (bone mineral and soft tissue) and that bone mineral has higher x-ray attenuation than soft tissue (52) .
Fat mass and fat-free soft tissue mass are then determined by mathematical algorithms, based on several assumptions, such as soft tissue overlying bone and soft tissue adjacent to bone have the same tissue composition; that there is a linearbased ratio of fat and fat-free mass in soft tissue and distribution throughout the body and a constant hydration of fat-free mass, potassium content and tissue density (52, 53) .
DXA is considered to be a more accessible, quicker and a less expensive alternative to other imaging techniques such as MRI and CT (51 higher torso thickness limits and weight limits (~200 kg), but the accuracy and precision of these newer models for the assessment of body composition, is currently limited (52) .
Other practical considerations may also limit the use of DXA. These include lack of portability, not being routinely available for body composition purposes, contraindication in pregnancy, individuals needing to lie in the supine position, and the presence of metallic implants (17). It also requires trained operators and whilst radiation exposure is minimal, any non-essential radiation exposure, particularly when used for longitudinal purposes, requires justification as frequent indiscriminate use is discouraged (66) .
Body composition reference data derived from DXA is also emerging. DXA scans were used as part of the 1999-2004 USA National Health and Nutrition Examination Survey (NHANES). This work involved the use of whole-body scans using a QDR 4500A fan beam (Hologic, Inc, Bedford, MA) densitometer and obtained data on a large sample (>20, 000) of adults and children (67, 68) which may be useful for comparative purposes.
In summary, whilst DXA is a considered to be less costly than CT or MRI and a more accurate and precise method than anthropometry or BIA, it is apparent that DXA is not without limitations and practical difficulties, which affect its application and use in clinical practice. However, the use of DXA scans for the estimation of body composition in practice could potentially increase in the future, as there is emerging interest in the secondary, opportunistic use of routine regional spine and hip DXA scans for body composition purposes (17). Preliminary studies (69, 70) suggest that such regional scans and subsequent predictions of whole-body composition are similar to those obtained from whole-body scans, but further validation work is required in larger more diverse populations before routine utilisation.
Ultrasound scanning
Ultrasound scanning (USS), another form of imaging, widely available for decades, has been used in medical practice , in areas such as pregnancy, cardiovascular disease (71) and for the diagnosis of conditions affecting organs and soft tissues (72) . However, increasingly USS is being used as a method for the clinical assessment of body composition (73, 74, 75) . .s -1 respectively) , quantification and differentiation between tissues is therefore possible (76) .
Brightness (B)-mode ultrasound technologies, at frequencies between 1-10MHz have commonly been used for the measurement of tissue thickness, but newer commercial type devices using amplitude (A)-mode at a frequency of 2.5MHz are also available (75) . A-mode uses a narrow beam to scan tissue and produces spikes on a graph whereas B-mode uses a linear array (by combining A-mode signals from various directions) to produce two dimensional images (76) . Tissue depths (thicknesses) are typically determined by the subjective distinction of interfaces, followed by the quantification of the thickness of the relevant tissue using electronic (digital) calipers, and an average of three measurements (74) .
There are many attractions to USS as a technique to assess body composition. It has the capability to provide regional information on adipose and muscle thicknesses, differentiate between visceral and subcutaneous adipose tissue, and provide information on muscle structure and quality (77) . It is also widely available, portable, non-invasive, quick (~1-2 minutes per site), doesn't have limits in terms of size and weight, is less costly than other imaging techniques, , involves no radiation exposure and data can be stored electronically (66, 74, 78, 79) . As such, it has significant potential for use in clinical settings where assessment of body composition is inherently more difficult, e.g. critical care, maternal health and spinal cord injury (80, 81) .
Until recently, USS has been primarily used for the regional quantification of adipose tissue either for the assessment of subcutaneous adipose tissue in manner similar to skinfolds (e.g. at triceps, biceps, subscapular, suprailiac sites). It is alsoincreasingly used for the assessment of abdominal VAT and SAT (82) . Such clinical studies have examined differences in subcutaneous fat patterning in pregnancy (81, 83) , changes in upper and lower limb body composition following bariatric surgery (84) and the relationship between USS abdominal fat thicknesses, or indexes (such as abdominal wall fat index) with parameters of metabolic risk in diabetic and healthy populations (82, 85, 86 Increased consideration is also being given to USS as a potential technique for the quantification of skeletal muscle thickness and for determining muscle quality (74) .
When used for the quantification of skeletal muscle, measurements taken at various regional sites, (e.g. biceps, triceps, mid thigh (rectus femoris) and calf In addition to evaluating muscle mass, USS echo intensities, measured using standard USS machines, have emerged as a potential marker of muscle quality.
Echo intensities, are however, more difficult to quantify and are determined either by visual scoring or by use of computer aided grey scale analysis (77, 93 which could make it a cost effective method of monitoring longitudinal regional changes in response to various interventions (75) . Overall, it is important to emphasis that whilst an increasing interest in USS is evident, and the technology can be applied to clinical practice, further work is required before USS should be considered a valid and appropriate body composition method.
Bioelectrical impedance analysis
Bioelectrical impedance analysis (BIA) has been used in public health and clinical practice for some considerable time, first being developed to estimate body water, then further developed to estimate body composition and latterly to predict disease severity and prognosis (103) . BIA is considered to be safe, straightforward, minimally invasive, relatively inexpensive, and more reproducible (<1%) than skinfold measurements. Results are readily available, and several devices are portable, making it an attractive bedside method for the clinical assessment of total body water and body composition (104, 105) . As BIA technology has advanced, several methods and devices are available. As these devices have different assumptions and limitations, it is important that health care professionals using these devices have sufficient knowledge and understanding of these.
BIA involves the passage of painless low amplitude current through the body, allowing the measurement of resistance (R) and reactance (Xc). BIA assumes that the resistance of the length of a conductor of homogenous material and uniform cross-sectional area is proportional to its length and inversely proportional to its cross-sectional area. It also assumes that the resistance to a current is inversely proportional to the uniform distribution of total body water (TBW) and electrolytes. Additionally, it has also been questioned as to whether BIA-derived FM, FFM is able to predict clinical outcome any better than BMI (113).
The first and most widely used method of BIA is single frequency BIA, (SF-BIA).
Commonly used at a frequency of 50k Hz, it measures a weighted sum of extracellular water and intracellular water resistivity, whichcan be used to estimate However, further work is required to determine the utility of these latter measurements across diverse clinical populations. It is also worth noting that although the evidence is limited, measurements taken in the vertical versus supine position are likely to result in differences in ECW and ICW measurements, but not of total body water (115).
SF-BIA monitors that measure from foot-to-foot alone (which can also directly measure body weight) or, hand-to-hand alone are also available, which ake measurements in the vertical position. These devices are generally less costly than whole-body devices and are available to purchase and use in clinical and non-clinical and home settings. However, the data provided by such devices can be limited (e.g. may only provide % fat mass and not provide raw resistance and reactance data), and the use of foot-to-foot machines may be limited by manufacturers' upper weight limits. Like whole-body SF-BIA devices, the validity of these devices to accurately and reliably predict body composition has been questioned. Whilst, in healthy populations, foot-to-foot devices can be considered a useful alternative to wholebody devices, the validity of hand-to-hand devices has been particularly questioned Even though the use of BIA for the assessment of body composition in clinical populations has been regularly criticised (113) , it is still frequently used due to its practicality and relative low cost. Therefore, in a bid to derive more valid assessments that directly reflect tissue hydration and integrity, there is increasing interest and support for the use of 'raw' resistance and reactance data (121) . Two such variables are phase angle (PA) and bioelectrical impedance vector analysis (BIVA). Phase angle is derived from the relation between the direct measurements of resistance (R) and reactance (Xc) and calculated as follows: Phase angle (degrees) = arctangent (Xc/R) x (180/π) (121).
In healthy participants, PA values usually ranges between 5-7 o and whilst the physiological meaning of PA is not yet well understood, it is considered to be an indicator of intra-and extracellular water distribution and, as such, an indicator of cellular health. Higher values are considered to reflect greater cellular integrity and function, and it has also been used as an alternative to the gold standard potassium-40 to predict body cell mass (122 (122, 125) . PA has also been used to assess wound healing, whereby resistance (R) is considered to be a biomarker of cell growth with increases in resistance, suggestive of healing (126) . Furthermore, when used in the context of pressure ulcers, a low reactance (Xc) along with a low serum albumin was found to be a significant predictor of risk (127) . However, despite this growing body of evidence, there is insufficient evidence examining longitudinal changes in PA in response to therapeutic interventions.
Several reference values for PA, derived from large healthy populations, have been published (128, 129 BIVA to aid the interpretation of changes in body weight and body composition (134) and to assist in determining the validity of deriving body composition from BIA (121).
All impedance measurements require standardisation of the measurement protocol and several aspects should be considered. These include the need for the accurate measurement of height and weight, body and limb position, resting before measurements, controlling for the presence of metal or silicone implants, electrode position, timing of measurements, prior physical activity, bladder voiding, diuretics, ambient temperature, dietary and fluid intake including caffeine. Pregnancy or the presence of pace makers, both precluding the use of BIA (105, 135, 136) . The majority of these aspects are potentially difficult to standardise in the clinical setting and may provide other sources of error or act as barriers to use. However, some of these aspects may not be as crucial as once thought. For example, a minimum 4-hour fast prior to measurements has been commonly advocated. However, in a recent study of 55 healthy, young adults, of normal body weight demonstrated that although eating and drinking a standardised drink/meal prior to foot-to-foot SF-BIA measurements resulted in statistically significant differences in the estimation of body composition, the differences were small (median percentage change of 1%) and within the imprecision of the BIA technique. This suggests that whilst a fasted state is ideal, the adherence to strict protocols may not be necessary (137) , forearm in a neutral position and with the mean value of three maximum grip efforts of both dominant and non-dominant hands (143) . However, as other protocols exist which take measurements standing or in a supine position and utilize fewer or more handgrip efforts, the interpretation of data across studies can be difficult (144) .
The type of dynamometer can also influence results. The majority of studies used a Jamar dynamometer (Lafayette Instruments, Layfayette IN), considered by ASHT as the gold standard, but as it is relatively heavy and requires an initial ~1.6 kg of force to move the indicator; it may confound measurements in older or frail populations (144) . Therefore, alternative lighter dynamometers such as the Takei (Takei Scientific Instruments, Tokyo) or pneumatic squeeze dynamometer may be more appropriate in certain populations (145) .
Until recently, there has been limited normative handgrip-strength across the lifecourse. Commonly, data derived from a meta-analysis of 12 (n=3317 adults, >20
years of age), primarily USA studies, which conformed to the ASHT protocol and used a Jamar dynamometer, has been used (143) . However, normative centile curves derived from 12 UK studies of 60,803 observations of participants aged 5 to 90 years are now available (Tables 2a and 2b) . Although the studies used varying measurement protocols and dynamometers, only maximum values were used to produce the centiles. In addition, sensitivity analysis of the data suggests that the centile curves accommodate the protocol differences between studies (145). A weak grip-strength has been defined as strength at least 2.5 standard deviations below the gender-specific peak mean. However the use of reference data to interpret individual results should be done with consideration of how handgrip was measured and the population the reference data was derived from. Furthermore, grip-strength can be affected by psychological factors such motivation, anxiety, depression, cognition, sedatives, diseases affecting the hands (e.g. rheumatoid arthritis) and inflammation (9) , therefore these factors should also be considered when interpreting results.
As differences in muscle strength and responsiveness to interventions between upper and lower limbs have been observed (4, 146, 147) , the strength testing of lower versus upper limbs may be relevant. Knee extensor testing is commonly used in a range of populations and age groups and has been associated with disability and mortality. Various reference values are available. For example, in one large study of 2,784 older adults (mean age 74 + 3 years), who were followed up for a median of 5.9 years, values of <1.13 Nm/kg for men, and <1.01 Nm/kg for women were associated with a high risk of future mobility limitation (148).
However, knee extensor strength testing can be difficult, costly, time-intensive and the equipment required may not be routinely available. Furthermore, whilst differences in upper and lower limbs have been observed there is a suggestion that in healthy individual's grip-strength and knee extensor strength share a common construct and either could be used to determine muscle strength, with handgrip the preferred option due to its simplicity (149) . Whether this construct remains valid in the presence of disease requires further exploration.
The consequences of decreased muscle strength are functional impairment and reduced ability to perform activities of daily living (150) . Functional performance tests, appearing to have a stronger relationship with muscle strength than muscle mass, can therefore provide valuable proxy assessments (6, 151) . Such performance tests are considered clinically relevant, as they in turn have been associated with disability risk and mortality (152) . Common performance tests include walking / gait speed, 6-minute walk test, stair-climb test, timed up-and-go and chair-rise / sit-tostand. All of these are relatively simple and inexpensive tests to perform in the clinical setting (153) . Various reference data are available (Table 3 ). In the main, these apply to healthy older adults and further work is needed in more diverse populations to establish relevant cut-offs to aid comparison between studies, determine the prevalence of impairment and aid the development of targeted therapeutic interventions (154) .
Walking / gait speed is of particular interest as this has been found to be predictive of adverse outcomes such as future health status, hospitalisation and risk of falling, particularly in older individuals (150, 155) . Commonly measured as the individual's usual walking pace over a short 4-metre distance, it is a feasible and practical assessment within a clinical setting (156) . A usual gait speed <0.6 m/sec has been proposed as a diagnostic cut-off for 'dismobility' (157) and in chronic kidney disease, it has been demonstrated that each 0.1 m/sec decrease in gait speed is associated with a 26% higher risk of mortality (158) . Therefore, a change in gait speed could serve as a useful outcome measure for assessing interventions, but appropriate cutoffs in younger and more clinical and ethnically diverse populations are currently lacking.
Self-reported methods provide a more subjective assessment of physical function.
These include the sickness impact profile (159) (165), which capture functional related performance. Additionally, the subjective global assessment and the mini nutritional assessment tool which incorporate elements of functional assessment could be options for practice (166, 167) . It is, however, important to note that self-reported functioning does not always correlate with objective measures of function (164) . This could be because self-reported functioning is considered to be a dynamic, non-linear construct (168) . In addition, factors such as gender, age, recent health problems, personality traits, depression, anxiety, cognitive impairment, pain and health literacy can also influence the accuracy of self-reporting (169, 170, 171) .
'Ceiling' and 'floor effects' of a questionnaire have been observed and may also influence results (150, 172) .
Whilst these methods are applicable for the assessment and monitoring of muscle strength and physical performance per se, future work to elucidate the influence of nutritional interventions versus other interventions, such as exercise, on muscle strength and functional performance is required. In doing so, an integrated multidisciplinary approach will be necessary.
Conclusion
Advances in body composition techniques have undoubtedly led to an increased understanding of the role of tissue volume and mass, its quality, patterning, and functionality and how these reflect nutritional status and impact on health risk. These advances coupled with increasingly outcome-focused healthcare suggest that practice needs to evolve and move beyond current approaches (19, 173, 174 (66, 73, 74, 76, 80, 93, 99, 101) • Greater operator dependency than other imaging techniques 
